1·Objective to explore the etiopathology of liver, stomach, and intestinal cancer.
目的探讨肝癌、胃癌、大肠癌发病机理。
2·AIMS To study the large intestinal cancer clinico_pathologically in western Hunan.
目的对湘西地区大肠癌进行临床病理探讨。
3·Coping style of sufferers from intestinal cancer is an important research factor of this research.
肠癌患者的应对方式是本研究的重要内容之一。
4·Overweight increases significantly the risk of heart attack, stroke, intestinal cancer, and type-2 diabetes.
超重显著增加了心脏病发作、中风、肠癌和2型糖尿病的风险。
5·The high-risk population of large intestinal cancer was screened and surveilled with fecal occult blood test.
用大便隐血试验筛检和监测大肠癌高危人群；
6·Objective To study changes and clinical significances of plasma Lp and CEA in patients with intestinal cancer.
目的：测定大肠癌患者血浆脂蛋白和血脂含量，探讨其水平变化的临床意义。
7·Constipation in the long term will force your intestines to absorb harmful substances and cause intestinal cancer.
长期便秘会迫使肠道反复吸收有害物质，诱发肠癌。
8·Surgical management of acute colon obstruction caused by large intestinal cancer is a difficult and disputed problem.
大肠癌并发急性结肠梗阻的外科处理是普外临床医生经常遇到的问题。
9·This paper summarizes Drofessor Fan Zhongze 'clinical experience in the differentiation and treatment of intestinal cancer.
总结分析范忠泽教授以健脾为主辨治肠癌的临证思路。
10·Objective: To study the relationship between DCC gene expression and recurrence and reoperation of large intestinal cancer after radical operation.
目的：探讨DCC基因在大肠癌复发中的临床意义及其与再手术预后的关系。
1·Overweight increases significantly the risk of heart attack, stroke, intestinal cancer, and type-2 diabetes.
超重显著增加了心脏病发作、中风、肠癌和2型糖尿病的风险。
2·Studies in modern medicine showed that it can be used in the treatment of lung cancer, liver cancer, gastric cancer and intestinal cancer in clinic.
现代医学研究表明，具有抗凝血、杀虫、镇痛、生白作用，临床也用于肺癌、肝癌、胃癌、肠癌等多种肿瘤的治疗。
3·This paper summarizes Drofessor Fan Zhongze 'clinical experience in the differentiation and treatment of intestinal cancer.
总结分析范忠泽教授以健脾为主辨治肠癌的临证思路。
4·Constipation in the long term will force your intestines to absorb harmful substances and cause intestinal cancer.
长期便秘会迫使肠道反复吸收有害物质，诱发肠癌。
5·In the process, Malek noted that mice in which the breakdown of the kinase inhibitor was suppressed by genetic change have a significantly lower risk of suffering from intestinal cancer.
在这个过程中，马利克指出，在其中细分激酶抑制剂是抑制小鼠的遗传变化有一个从患肠癌的风险大大降低。